S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48

A Pullback In Clorox (NYSE:CLX) Is Your Chance To Buy

Monday, August 3, 2020 | Thomas Hughes
The #1 Pandemic Stock Is …

It’s hard to say, truly, which stock is the very best pandemic play because there have been so many great ones. Companies like Tractor Supply Company (NASDAQ: TSCO), Logitech (NASDAQ: LOGI), and Clorox (NYSE: CLX) have all proven their worth in today’s climate. Shares prices for these stocks have not only rebound from their March lows but they have also marched to new highs, new all-time highs in the cases of the stocks mentioned.

In the case of Clorox, the company is well-positioned as not only the leading maker of household disinfectants but also many other common household brands we all know and love. Among them are KC Masterpiece, Kingsford, Hidden Valley (the ranch people), and Burt’s Bees.

The rush to pantry-loading caused a surge in demand across the company’s product line it is still struggling to catch up with. Earlier this year, Clorox execs let it be known demand for some of its disinfectant products increased 500%. The surge was described as an event no supply chain could handle. A the time, they did not expect to catch up with the surge until mid-summer and, based on my local store shelves, they haven’t yet.

“The Clorox Company reported a 22% sales increase, including double-digit growth across all reportable segments, and a 28% increase in diluted net earnings per share (diluted EPS) for its fourth quarter”

Clorox Revenue Growth Accelerates Into The 2nd Quarter

Clorox just released its fiscal 4th quarter, calendar 2nd quarter results and smashed through consensus. For this company, that’s saying something because consensus for growth was running in the mid-teens and the estimates had been rising. On the top line, Clorox delivered revenue of $1.98 billion or up 21.5% versus the consensus 15%. Organic sales increased 24% versus the 17.1% forecast, and EPS came in well above expectations too. At the GAAP level, EPS of $2.41 beat by $0.40.

To be fair, the strength is not entirely due to COVID-19. The Clorox Company has been executing an aggressive growth strategy they call the Ignite Strategy. The strategy’s focus is to build out the brand portfolio in order to promote and sustain long-term growth. Over the course of the last quarter, Clorox increased its stake in a joint venture supplying cleaning products in the Persian Gulf region.

"Guided by our IGNITE Strategy, we remain committed to building on this momentum through deliberate and aggressive investments to support our ambition of accelerating long-term sales growth."

Looking forward, the company is expecting to post strong results in fiscal 2021 but the comps are going to be tough. The company sustained an 8% revenue growth rate in 2020 that will be tough to beat. The silver lining is that revenue growth accelerated into the end of the fiscal year and show no signs of slowing. The consensus for the upcoming quarters does not yet reflect that strength and likely too low. Ironically, the average analysts’ rating is neutral with a bearish bias.

Clorox Technical Outlook: Profit Taking Is Your Opportunity For Entry

Today’s news, despite its robustness, failed to spark a rally in Clorox shares. Instead, profit takes and short-sellers have the price action down about 2.5% but I don’t think the discount will last. Early action is already showing signs of support above the short-term moving average where I would expect to see a trend-following bounce form. In the near-term, price action may continue to move sideways at or near today’s levels before moving higher.

Don’t forget, Clorox pays a dividend worth 1.88% and comes with a high degree of safety and a higher expectation for future increase. Clorox has been increasing its yield for 43 years, including this one. Longer-term, Clorox brand recognition is growing and that will support growth, profits, and capital returns to shareholders.

A Pullback In Clorox (NYSE:CLX) Is Your Chance To Buy
7 Manufacturing Stocks That Will Overcome Current Difficulties

The manufacturing industry was one of the hardest hits in 2020. In the initial months of the coronavirus pandemic, many companies were forced to shutter operations. However, opportunistic investors kept their eye on several of these companies as recovery stocks. And at the beginning of 2021, the emergence of several vaccines allowed businesses to reopen.  Not surprisingly, manufacturing stocks were among the biggest winners.

But where are these stocks headed in 2022? In December, American manufacturers reported their slowest pace of growth in 11 months. A closely followed index of U.S.-based manufacturers dropped to 58.7% in the final month of 2021. This was slightly lower than the 61.1% in November according to the Institute for Supply Management.

Still, any number of above 50% signals expansion. And the number is only slightly below the 60% level that signifies exceptional growth.

Ironically, it’s the virus that continues to provide a headwind. Supply chains are unwinding but not nearly fast enough to prevent material shortages. The controversy surrounding vaccine mandates is causing labor shortages.

However, there’s a strong likelihood that manufacturing stocks will have a strong year in 2022. And even if they don’t, many of these stocks pay a reliable dividend. That’s why we’ve put together this special presentation on the manufacturing stocks that will overcome current difficulties.

View the "7 Manufacturing Stocks That Will Overcome Current Difficulties".

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Tractor Supply (TSCO)2.7$220.66-0.3%0.94%28.15Buy$226.05
Logitech International (LOGI)2.3$79.39-1.5%N/A14.62Hold$107.50
Clorox (CLX)2.5$181.13+0.1%2.56%52.35Hold$172.38
Compare These Stocks  Add These Stocks to My Watchlist 


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.